[1]
|
Castelli WP. 1984. Epidemiology of coronary heart disease: the Framingham study. The American Journal of Medicine, 76(2A): 4-12.
|
[2]
|
Clark BT. 1997. The natural history of amphibian skin secretions, their normal functioning and potential medical applications. Biological Reviews of the Cambridge Philosophical Society, 72(3): 365-379.
|
[3]
|
Cui YF, Li ZL, Zhao EP, Jia YF, Li DH, Zhang J, Cui NQ. 2011. Overexpression of sterol carrier protein 2 in patients with hereditary cholesterol gallstone. BMC Gastroenterology, 11: 10.
|
[4]
|
Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R. 2009. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells, Molecules, and Disease, 28(2): 160-168.
|
[5]
|
Hu QL, Zhang SF, Yang XY, Yu MH, Zhuge H. 2013. Bufo gargarizans mcl-1 cloning and its prokaryotic recombinant protein expression. Acta Pharmaceutica Sinica, 48(10): 1624-1628. (in Chinese)
|
[6]
|
Kriska T, Pilat A, Schmitt JC, Girotti AW. 2010. Sterol carrier protein-2 (SCP-2) involvement in cholesterol hydroperoxide cytotoxicity as revealed by SCP-2 inhibitor effects. The Journal of Lipid Research, 51(11): 3174-3184.
|
[7]
|
Lai R, Liang JG, Zhang Y. 2004. Antimicrobial peptides in amphibian skins and their application. Zoological Research, 25(5): 465-468. (in Chinese)
|
[8]
|
Lai R, Zhao Y, Yang DM, Zha HG, Lee WH, Zhang Y. 2002a. Comparative study of the biological activities of the skin secretions from six common Chinese amphibians. Zoological Research, 23(2): 113-119. (in Chinese)
|
[9]
|
Lai R, Zhao Y, Liu H, Zhang YJ, Lee WH, Zhang Y. 2002b. Bioactive substance of amphibian skin and a study on exploitation and utilization of Chinese amphibian resources. Zoological Research, 23(1): 65-70.(in Chinese)
|
[10]
|
Liu JS, Zhang DM, Kurihara H, Ye WC. 2009. Antitumor effects of venenum bufonis and its active components. Journal of International Pharmaceutical Research, 36(2): 115-120.(in Chinese)
|
[11]
|
McLean MP, Warden KJ, Sandhoff TW, Irby RB, Hales DB. 1996. Altered ovarian sterol carrier protein expression in the pregnant streptozotocin-treated diabetic rat. Biology of Reproduction, 55(1): 38-46.
|
[12]
|
Novkovi? M, Simuni? J, Bojovi? V, Tossi A, Jureti? D. 2012. DADP: the database of anuran defense peptides. Bioinformatics, 28(10): 1406-1407.
|
[13]
|
Osumi T, Hashimoto T, Ui N. 1980. Purification and properties of acyl-CoA oxidase from rat liver. The Journal of Biochemistry, 87(6): 1735-1746.
|
[14]
|
Qi FH, Li AY, Zhao L, Zhang L, Du GH, Tang W. 2010. Apoptosis-inducing effect of cinobufacini on human hepatoma cell line HepG2 and its mechanism of action. Acta Pharmaceutica Sinica, 45(3): 318-323. (in Chinese)
|
[15]
|
Qi FH, Li AY, Inagaki Y, Kokudo N, Tamura S, Nakata M, Tang W. 2011. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. International Immunopharmacology, 11(3): 342-349.
|
[16]
|
Rash LD, Morales RA, Vink S, Alewood PF. 2011. De novo sequencing of peptides from the parotid secretion of the cane toad, Bufo marinus (Rhinella marina). Toxicon, 57(2): 208-216.
|
[17]
|
Schroeder F, Atshaves BP, McIntosh AL, Gallegos AM, Storey SM, Parr RD, Jefferson JR, Ball JM, Kier AB. 2007. Sterol carrier protein-2: New roles in regulating lipid rafts and signaling. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1771(6): 700-718.
|
[18]
|
Schroeder F, Frolov O, Starodub BB, Atshaves W, Russell A, Petrescu H, Huang H, Gallegos AM, McIntosh A, Tahotna D, Russell DH, Billheimer JT, Baum CL, Kier AB. 2000. Pro-sterol carrier protein-2: role of the N-terminal presequence in structure, function, and peroxisomal targeting. The Journal of Biological Chemistry, 275(33): 25547-25555.
|
[19]
|
Tong ZY. 2011. The research progress of antitumor effects of venenum bufonis. Journal of Military Surgeon in Southwest China, 13(2): 310-312. (in Chinese)
|
[20]
|
Wu X, Gao B, Yang J, Bian BL, Wang HJ. 2012. In vitro anti-proliferation effect of peptides from cinobufacini injection. Acta Pharmaceutica Sinica, 47(6): 822-826. (in Chinese)
|
[21]
|
Xin XL, Zhang BJ, Su DH, Deng S, Huang SS, Ma XC. 2012. Pharmacology advances in studies on Bufo bufo gargarizans. Progress in Modern Biomedicine, 12(3): 588-590, 600. (in Chinese)
|
[22]
|
Yuan JQ, Xu Y, Yang XY, Zhuge H, Zhang SF. 2013. Cloning and sequence analysis of clusterin cDNA of Bufo japonicus formosus. Biotechnology Bulletin, (1): 156-161. (in Chinese)
|
[23]
|
Zhang SF, Yuan JQ, Huang H, Zhuge H, Xu Y, Yang XY. 2013. Cloning and bioinformatics analysis of MCL-1 cDNA of Bufo japonicus formosus. Biotechnology Bulletin, (4): 179-184. (in Chinese)
|
[24]
|
Zhao F, Yan C, Wang X, Yang Y, Wang GY, Lee WH, Xiang Y, Zhang Y. 2014. Comprehensive transcriptome profiling and functional analysis of the frog (Bombina maxima) immune system. DNA Research, 21(1): 1-13.
|
[25]
|
Zhou X, Yang JK, Zhu LQ, Gao F, Xie RF, Gu XJ. 2009. Meta analysis on cinobufacini injection in hepatocellular carcinoma after transcatheter arterial chemoembolization. Chinese Journal of New Drugs and Clinical Remedies, 28(9): 671-674. (in Chinese)
|
[26]
|
Zhuge H, Yuan JQ, Zhang SF, Yang XY. 2013. Cloning and bioinformatic analysis of TAGLN2 cDNA of Bufo japonicus formosus. Acta Pharmaceutica Sinica, 48(2): 250-254. (in Chinese)
|